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Changing Physical Activity Behavior in
Type 2 Diabetes
A systematic review and meta-analysis of behavioral interventions
LEAH AVERY, MSC1
DARREN FLYNN, PHD2
ANNA VAN WERSCH, PHD3
FALKO F. SNIEHOTTA, PHD2
MICHAEL I. TRENELL, PHD1
OBJECTIVEdBehavioral interventions targeting “free-living” physical activity (PA) and exer-
cise that produce long-term glycemic control in adults with type 2 diabetes are warranted.
However, little is known about how clinical teams should support adults with type 2 diabetes
to achieve and sustain a physically active lifestyle.
RESEARCHDESIGNANDMETHODSdWe conducted a systematic review of random-
ized controlled trials (RCTs) (published up to January 2012) to establish the effect of behavioral
interventions (compared with usual care) on free-living PA/exercise, HbA1c, and BMI in adults
with type 2 diabetes. Study characteristics, methodological quality, practical strategies for in-
creasing PA/exercise (taxonomy of behavior change techniques), and treatment fidelity strategies
were captured using a data extraction form.
RESULTSdSeventeen RCTs fulfilled the review criteria. Behavioural interventions showed
statistically significant increases in objective (standardized mean difference [SMD] 0.45, 95% CI
0.21–0.68) and self-reported PA/exercise (SMD 0.79, 95% CI 0.59–0.98) including clinically
significant improvements in HbA1c (weighted mean difference [WMD] –0.32%, 95% CI –0.44%
to –0.21%) and BMI (WMD –1.05 kg/m2, 95% CI –1.31 to –0.80). Few studies provided details
of treatment fidelity strategies to monitor/improve provider training. Intervention features (e.g.,
specific behavior change techniques, interventions underpinned by behavior change theories/
models, and use of $10 behaviour change techniques) moderated effectiveness of behavioral
interventions.
CONCLUSIONSdBehavioral interventions increased free-living PA/exercise and produced
clinically significant improvements in long-term glucose control. Future studies should consider
use of theory and multiple behavior change techniques associated with clinically significant
improvements in HbA1c, including structured training for care providers on the delivery of
behavioural interventions.
Diabetes Care 35:2681–2689, 2012
The global prevalence of diabetes ispredicted to increase from 171 mil-lion individuals (2.8%) in 2000 to
336 million (4.4%) in 2030 (1). Because
the increase in prevalence is most marked
in younger adults, the disease is expected
to inflict a devastating toll on the future
working-age population in terms of pre-
mature coronary heart disease, amputa-
tions, and blindness (2). The main causal
risk factor for type 2 diabetes is an imbal-
ance between energy expenditure and en-
ergy intake through food consumption
(3,4). Drug-based interventions are un-
likely to provide the solution to this wide-
spread problem and interventions aimed
at increasing energy expenditure through
physical activity may provide an effective
alternative, because the majority of peo-
ple with type 2 diabetes are physically
inactive when compared with national
averages (5).
Physical activity (PA; regular move-
ment such as walking) and exercise
(structured activities such as running or
cycling), along with diet and medication,
are the cornerstones of diabetes manage-
ment (6). Several reviews (7,8) and meta-
analyses (6,9–11) report that increased
PA and/or exercise produce a significant
improvement in glucose control in people
with type 2 diabetes, yielding an average
improvement in hemoglobin A1c (HbA1c)
of between 20.4% and 20.6%. Despite
the clear benefits of increased PA and ex-
ercise upon glycemic control, little is
known about how clinical care teams
should support people with diabetes to
achieve and sustain a physically active
lifestyle. This evidence-practice gap is se-
riously hindering the effectiveness of PA
and exercise as a therapeutic intervention
in routine diabetes care.
Behavioral interventions targeting PA
and exercise are heterogeneous in terms
of content, implementation, and effec-
tiveness. Interventions differ on a range of
dimensions, for example, the theory of
behavior change used to underpin them;
the behavior change techniques used to
encourage change (e.g., goal setting, use
of follow-up prompts); and delivery of the
intervention (e.g., frequency and dura-
tion of contact; one-to-one vs. group
delivery). Working around a theory or
model of behavior change may assist
selecting, sequencing, and communicat-
ing relevant behavior change techniques.
Techniques, in turn, describe the means
of operationalization, e.g., what interven-
tionists do to bring about change, regard-
less of the use of explicit theory. Despite
the benefits of behavior change theory
and specific theory-linked behavior
change techniques (12,13), historically
behavioral interventions have frequently
omitted adequate descriptions of the spe-
cific theory or model of behavior change
used, explicit details of intervention con-
tent, and how this was operationalized
and evaluated (14), limiting the efficacy
of the intervention and replication out-
side the research setting. Elucidating the
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theory, content, and delivery of interven-
tions may help to explain the heterogene-
ity in effect sizes usually observed in
systematic reviews and, thereby, to iden-
tify what works and what does not, which
provides the evidence needed to direct
clinical care and research.
Our objective was to conduct a sys-
tematic review to answer the following
questions: are behavioral interventions
more effective than standard clinical care
for improving “free-living” PA and exer-
cise and HbA1c in adults with type 2 di-
abetes in clinical or community settings,
and what behavior change theories or the-
ory-linked behavior change techniques
(and other features of behavioral interven-
tions) are associated with clinically signifi-
cant improvements in HbA1c?
RESEARCH DESIGN AND
METHODSdThis systematic review
followed a published protocol (15) and
the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA)
guidelines (16).
Inclusion criteria
Studies were randomized controlled trials
(RCTs) of behavioral interventions target-
ing free-living PA and exercise in adults
(18 years or older) with type 2 diabetes
(controlled by diet or oral medication or
insulin therapy) with a minimum follow-
up period of 1 month from baseline. In-
terventions were delivered in clinical and
community settings. Studies also in-
cluded the primary outcomes: change in
level of PA and exercise and change in
HbA1c.
Exclusion criteria
Studies were excluded if interventions
targeted PA and exercise and diet, al-
though studies were retained if all study
participants received a dietary compo-
nent that was consistent with usual care.
Studies were also excluded if they targeted
multiple chronic diseases; gestational
diabetes or had no focus on engaging in
free-living PA and exercise outside of
supervised sessions. Studies that included
the following components were also ex-
cluded: combinations of diet or pharma-
cological agents with PA and exercise in
one arm of the trial; comparisons of
pharmacological agents alongside and
against PA and exercise; or comparisons
of different behavioral interventions tar-
geting PA and exercise that did not
include a comparison arm that consti-
tuted usual care.
Search strategy
PsycINFO, Medline, CINAHL, EMBASE,
Scopus, and the Cochrane Library were
searched using a combination of MeSH
headings and key words to identify poten-
tially relevant literature (Supplementary
Table 1). Searches were completed up to
January 23, 2012, and were limited to
RCTs published in the English language.
Manual searching of reference lists and ci-
tation searching of studies fulfilling the
eligibility criteria were also conducted.
Selection of studies
Two authors independently screened the
titles and abstracts of articles. Articles
retained at the first stage were reassessed
independently for inclusion by the same
two authors using a study selection form,
with disagreements resolved via discus-
sion with the review team.
Data extraction
Details on the study population, inter-
ventions, comparators, and outcomes
were captured using a structured data
extraction form. All included studies un-
derwent independent assessment by at
least two of the authors (disagreements
were resolved via discussion). Corre-
sponding authors of included studies
were contacted via e-mail to request
additional data when applicable. The
Cochrane Collaboration risk of bias tool
(17) was used to appraise methodological
quality and assess overall risk of bias (low,
unclear, or high) within and across stud-
ies for each outcome. Data on treatment
fidelity were assessed using published
guidance (18). Descriptions of interven-
tion content were coded into specific
theory-linked behavior change techniques
using a reliable and comprehensive tax-
onomy for intervention techniques target-
ing PA (19). Behavior change techniques
utilized in both intervention and usual
care groups were not coded to enable
identification of those techniques that
could be attributed to changes in
outcomes.
Data synthesis
Data on changes in PA and exercise,
HbA1c, and BMI were synthesized using
meta-analytic techniques (RevMan v5.1,
Cochrane IMS). Studies reporting suffi-
cient data to enable calculation of effect
sizes were included in meta-analyses.
Random effects models were selected to
allow for between-group and within-
group differences (17). When studies in-
cluded multiple trial arms, data on each
intervention arm compared with the usual
care arm were included in meta-analyses.
Excessive weightings were controlled in
studies with multiple intervention arms,
consistent with published guidance (17).
Heterogeneity was assessed using I2, with
values .50% considered heterogeneous
(20). Measures of intervention effects on
PA and exercise, HbA1c, and BMI are pre-
sented as a function of timing of follow-up
measurements: $1 month to ,6 months
(short-term); 6 months (short-term to
medium-term); 12 months (medium-
term); and 24 months (long-term). Overall
measures of effect for interventions repre-
sent average effect sizes across these follow-
up periods.
To account for variation in the meth-
ods used to assess PA and exercise across
studies, objective measures (accelero-
meter [activity counts and/or minutes spent
active] and pedometer [steps]) were com-
bined in meta-analyses. Self-reported data
on PA and exercise were combined if
sufficient information was provided
about the content of the measures (i.e.,
7-day recall of PA and conversion of activity
intensity into MET values or minutes/
hours spent active). Sensitivity analyses
were undertaken by excluding outlying
studies and any with negative ratings on
indices of methodological quality.
Moderator analyses were conducted
on characteristics of behavioral interven-
tions identified in a minimum of three
studies to explore any impact on change
in HbA1c ($20.30% HbAlc as a cutoff
value for a clinically significant improve-
ment). These analyses should be consid-
ered exploratory and were undertaken to
identify any potential foci of future re-
search and clinical practice.
RESULTSdNineteen articles reporting
17 RCTs (21–37) fulfilled the review cri-
teria (Supplementary Fig. 1). Two RCTs
(27,30) were reported across two articles
(38,39). For another four RCTs
(21,29,36,37), additional articles were
consulted to obtain information on inter-
vention content (40–47).
Eleven RCTs were conducted in Eu-
rope (21,22,24–28,30–32,37), two in
Australia (23,35), three in North America
(33,34,36), and one in Asia (29). Authors
of 13 RCTs utilized a theory/model of be-
havior change to develop and deliver
interventions: Transtheoretical Model
(29–31,37); Social Cognitive Theory
(21,22,27,36); and Precede/Proceed
Model (35). Four studies stated that inter-
ventions were underpinned by multiple
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theories/models: Transtheoretical Model
and Social Cognitive Theory (34); Cogni-
tive Behavioral Therapy; Motivational In-
terviewing; and Social Cognitive Theory
(24–26).
The studies had a combined total
sample size of 1,975. Eight studies in-
cluded approximately equal numbers of
women and men (25,27–31,36,37),
whereas nine studies had disproportion-
ate numbers of women (23,32–35) and
men (21,22,24,26). Participants were,
on average, aged between 51 and 55
(29,33,36,37), 58 and 59 (21,30), 60
and 64 (22,23,26–28,31,32,34,35), or
66 and 70 years (25). One study included
participants aged 35 to 75 years (24). In-
formation on time since diagnosis was
described in 11 studies (21,22,24–
27,29,31,32,34,36). Twelve studies (21–
23,25–27,29,31,32,35–37) reported
sufficient information on management
of type 2 diabetes (diet, oral medication,
and/or insulin therapy). A summary of
the key characteristics of the 17 RCTs
can be found in Supplementary Table 2.
Methodological quality assessment
and treatment fidelity
Supplementary Table 3 presents details of
methodological quality assessment and
overall risk of bias within and across stud-
ies for each outcome. Eight studies pro-
vided sufficient information to establish
the use of adequate randomization se-
quences (21,25,27,28,30,31,33,34). Six
studies provided sufficient detail on the
methods used to conceal allocation se-
quences (21,24,25,30,31,33). Seven stud-
ies provided explicit detail on the use of
blinding of care providers (22,37) or out-
come assessors (21,24,25,31,33). The ma-
jority of studies provided sufficient detail
to establish the likely absence of selective
outcome reporting, incomplete outcome
data, and other potential sources of bias.
Twelve studies reported a power cal-
culation (21,22,24–31,33,34), with nine
reporting achievement of required sample
sizes at final follow-up (21,22,26–31,34).
One study had an attrition rate of .20%
at final follow-up (36). Eleven studies re-
ported using an intention-to-treat anal-
ysis (21,22,24–28,30,31,33,34). The
overall risk of bias for HbA1c, self-reported
PA, and BMI was graded as “unclear,” and
“low” for objectively assessed PA.
The treatment fidelity assessment
(Supplementary Table 4) identified that
all 17 studies provided sufficient detail
to establish the use of treatment fidelity
strategies related to study design (e.g.,
measures taken to ensure length/duration
and frequency of contact within interven-
tion groups).
Five studies referred to training of
interventionists (21,25,29–31), although
only two studies explicitly described
strategies for monitoring and improving
interventionist training (21,25). Fourteen
studies described methods to improve
delivery of interventions (21,22,24–
27,29–31,33–37) (e.g., providing frequent
supervision to interventionists, using
scripted intervention protocols, and tak-
ing steps to control contamination across
intervention and usual care groups). All 17
studies provided sufficient detail to estab-
lish use of strategies to monitor and im-
prove the ability of patients to understand
the intervention-related cognitive and be-
havioral skills and strategies to monitor
and improve enactment of intervention-
related skills in relevant real-life settings
(e.g., prompting participants to set goals,
self-monitoring of progress, conducting
follow-up discussions and telephone
calls, and opportunities for participants
to review the effect of increased PA on
blood glucose levels).
Changes in PA and exercise
Behavioral interventions (compared with
usual care) showed a statistically signifi-
cant increase in levels of objectively as-
sessed PA and exercise (standardized
mean difference [SMD] = 0.45, 95%
CI = 0.21–0.68, I2 = 55%) based on data
from six studies (24,25,26,30,31,36)
(Fig. 1). With the exception of 6 months,
this effect was found for the follow-up pe-
riod $1 month to ,6 months (SMD =
0.70, CI = 0.36–1.04, I2= 0%) and 12
months (SMD = 0.42, CI = 0.04–0.80, I2
= 57%). Sensitivity analyses (exclusion of
one study with a high attrition rate) (36)
resulted in a slight decrease in magnitude
of the overall effect (SMD = 0.41, CI =
0.15–0.66, I2 = 58%) and at the $1
month and ,6 months follow-up period
(SMD = 0.59, CI = 0.18–1.00, I2= 0%).
Likewise, the 14 RCTs providing self-
reported PA and exercise data showed an
overall significant positive intervention
effect (SMD = 0.79, 95% CI = 0.59–0.98,
I2 = 74%) (21–23,25–27,29–35,37) (Sup-
plementary Fig. 2). These effects were
maintained across all follow-up periods,
with the exception of 24 months.
Changes in HbA1c
Behavioral interventions (compared with
usual care) showed statistically and clinically
significant improvements in HbA1c
(weighted mean difference [WMD] =
20.32%, 95% CI = 20.44 to –0.21%,
I2 = 8%) based on data from 17 studies
(21–37) (Fig. 2). With the exception of
$1 month to,6 months, statistically sig-
nificant improvements were found across
all follow-up periods: 6 months (WMD =
20.33%, CI =20.67 to 0.00%, I2 = 38%);
12 months (WMD = 20.33%, CI = 20.48
to 20.18%, I2 = 0%); and 24 months
(WMD =20.56%, CI =20.82 to20.30%,
I2= 0%). Removal of a study with a high
attrition rate (36) did not change the
conclusions regarding the overall effect.
Changes in BMI
Behavioral interventions targeting PA and
exercise (comparedwith usual care) showed
an overall statistically significant reduction
in BMI (kg/m2) based on data from
11 studies (21–25,27,28,30,31,33,37)
(WMD = 21.05 kg/m2, 95% CI = 21.31
to20.80, I2 = 2%) (Supplementary Fig. 3).
Adecrease in BMIwas evident across follow-
up periods: $1 month to ,6 months
(WMD = 20.75 kg/m2, CI = 21.22 to
20.28, I2 = 0%); 6 months (WMD =
20.77 kg/m2, CI = 21.39 to 20.15, I2=
20%); 12 months (WMD = 21.32 kg/m2,
CI = 21.73 to 20.90, I2 = 0%); and 24
months (WMD = 21.52 kg/m2, CI =
22.23 to20.81, I2= 0%).
Moderators of intervention
effects on HbA1c
Twenty-five different behavior change
techniques were identified across the 17
studies (Supplementary Table 5). The
studies used a minimum of two and a
maximum of 14 behavior change techni-
ques (median 10, IQR 8).
Exploratory moderator analyses com-
paring effect size estimates for trials with
or without a range of intervention features
(i.e., behavior change techniques, modes
of delivery, and theory use, Table 1) sug-
gested that effects varied considerably. Al-
though these differences do not equate
to statistical significance reflecting the
limited power based on the current evi-
dence, these analyses suggest that utiliza-
tion of 10 different behavior change
techniques within behavioral interven-
tions may be associated with clinically
significant improvements in HbA1c
($0.3% HbA1c): prompting generaliza-
tion of a target behavior; use of follow-up
prompts; prompt review of behav-
ioral goals; provide information on
where and when to perform PA; plan
social support/social change; goal
setting (behavior); time management;
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prompting focus on past success; barrier
identification/problem-solving; and pro-
viding information on the consequences
specific to the individual.
Clinically significant improvements
in HbA1c were also suggested for studies
utilizing more behavior change techni-
ques (median$10), interventions under-
pinned by a theory or model of behavior
change, and durations of $6 months.
These analyses also suggested that dif-
ferent modes of intervention delivery,
interventions utilizing pedometers, inter-
ventions of greater intensity (median$14
contacts), and inclusion of a supervised
PA and exercise component were not
associated with clinically significant im-
provements in HbA1c.
CONCLUSIONSdThere is evidence
to report that behavioral interventions
(with low or unclear risk of bias) target-
ing increased PA and exercise produce
a clinically significant improvement
in HbA1c in adults with type 2 diabe-
tes. Specific behavior change techniques
may increase the likelihood of clinically
significant improvements in HbA1c.
Regarding utilization of behavior change
techniques, more might be better.
Other intervention features such as utili-
zation of theory and intervention dura-
tion may also impact upon intervention
effectiveness.
A strength of this dataset is that all
studies were undertaken in clinical care or
community settings, demonstrating po-
tential clinical utility. The major implica-
tion of this review is that behavioral
interventions have potential to effectively
reduce HbA1c in adults with type 2 diabe-
tes in routine clinical care. The reductions
in HbA1c of 0.21 to 0.44% are consistent
with previous meta-analyses, including a
wider collection of PA and exercise stud-
ies (6–11). Follow-up periods of ,6
months failed to show a significant impact
onHbA1c. However,,6months duration
is not sufficient to elicit an observable ef-
fect on HbA1c, highlighting that longer
behavioral interventions are needed if
clinically meaningful changes in HbA1c
are desired. The benefits to glycemic con-
trol were sustained for up to 24 months
(Fig. 2) and were comparable with com-
mon long-term drug or insulin therapy
(48,49). Potential limitations of this re-
view are the disparate definitions of
“usual care” across studies and the possi-
bility of selection and/or performance and
detection bias attributable to either
absence or lack of reporting on allocation
concealment and blinding, respectively.
However, blinding of participants and
study personnel is inherently problem-
atic in behavioral studies. Publication
bias is possible, although an inspection
of funnel plots for primary outcomes
did not show any substantial asymmetry,
indicating a low risk of publication or small
study bias.
Critically, all studies reviewed in-
volved supporting adults with diabetes
to undertake free-living PA and exercise.
Despite the focus on PA and exercise,
meta-analyses reported significant het-
erogeneity for objective (Fig. 1) and self-
reported PA (Supplementary Fig. 2).
Although there were individual differ-
ences in response, the variations in sensi-
tivity and specificity in monitoring PA and
exercise between the different objective
and self-reported methods observed will
have contributed to this heterogeneity.
The lack of accurate, standardized, and
transparent methods for monitoring PA
and exercise remains a significant barrier
to accurately determining the efficacy of
interventions targeting free-living PA and
exercise and should be addressed in fu-
ture studies. This lack of sensitivity also
makes describing what participants are
Figure 1dForest plot for objective PA and exercise. (A high-quality color representation of this figure is available in the online issue.)
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doing difficult, limiting discussion about
what type, intensity, and frequency are
minimal and optimal to confer benefit.
Furthermore, many interventions reported
reductions in BMI (Supplementary
Fig. 3). Because PA or exercise alone is
generally insufficient to incur weight
loss (50), this suggests an impact of be-
havioral interventions targeting PA and
exercise on calorie intake, and Hawthorne
effects cannot be ruled out. Further-
more, there is a complex relationship
betweenmode and intensity of activity, nu-
trition, and the behavioral methods used
to achieve these that is not addressed in
this article. However, the lack of detail
about calorie intake or different modes
of PA and exercise should not detract
Figure 2dForest plot for HbA1c. (A high-quality color representation of this figure is available in the online issue.)
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from the reported clinical utility of be-
havioral interventions targeting PA and
exercise in terms of long-term glucose
control.
The studies identified used a range of
behavior change theories and behavior
change techniques that may moderate the
effectiveness of the behavioral interven-
tions. Although effect sizes found in
moderator analyses do not differ signifi-
cantly from the main findings, they help
identify specific candidate behavior
change techniques most likely to be
effective for future research and as potential
foci for clinical practice. Ten behavior
change techniques (19) were associated
with potential clinically significant im-
provements in HbA1c: prompting general-
ization of a target behavior (e.g., once
PA is performed in one situation, the
individual is encouraged to try it in
another); use of follow-up prompts (e.g.,
telephone calls in place of face-to-face ses-
sions to supportmaintenance); prompt re-
view of behavioral goals (e.g., review
whether PA goals were achieved followed
by revisions or adjustments); providing
information on where and when to be
active (e.g., tips on places and times to
access local PA and exercise clubs); plan
social support and social change (e.g.,
encourage individuals to elicit social sup-
port from others to help achieve a PA-
related goal); goal setting (e.g., supporting
individuals to formulate specific, mea-
surable, achievable, relevant, and timely
PA-related goals); time management
(e.g., making time to be active); prompt-
ing focus on past success (e.g., identifying

















a target behavior 5 (18) 190 (1,644) 20.73 (21.16 to 20.31) 20.29 (20.44 to 20.15) 20.44
Use of follow-up prompts 16 (7) 1,056 (778) 20.50 (20.67 to 20.33) 20.14 (20.36 to 0.08) 20.36
Goal setting (outcome) 3 (20) 123 (1,711) 20.65 (21.23 to 20.07) 20.32 (20.46 to 20.17) 20.33
Prompt rewards contingent on
effort/progress toward behavior 3 (20) 123 (1,711) 20.65 (21.23 to 20.07) 20.32 (20.46 to 20.17) 20.33
Prompt review of behavioral goals 14 (9) 920 (914) 20.50 (20.69 to 20.32) 20.17 (20.40 to 0.05) 20.33
Provide information on where and
when to perform the behavior 10 (13) 747 (1,087) 20.54 (20.74 to 20.34) 20.24 (20.39 to 20.09) 20.30
Plan social support/social change 13 (10) 894 (940) 20.50 (20.69 to 20.32) 20.20 (20.41 to 0.01) 20.30
Goal setting (behavior) 17 (6) 1,019 (815) 20.44 (20.61 to 20.27) 20.16 (20.47 to 0.15) 20.28
Prompting focus on past success 4 (19) 415 (1,419) 20.54 (20.80 to 20.29) 20.29 (20.44 to 20.13) 20.25
Provide information on consequences
of behavior to the individual 5 (18) 476 (1,358) 20.51 (20.75 to 20.28) 20.29 (20.46 to 20.12) 20.22
Barrier identification/problem-solving 15 (8) 1,016 (818) 20.44 (20.61 to 20.26) 20.23 (20.48 to 0.02) 20.21
Time management 8 (15) 630 (1,204) 20.47 (20.68 to 20.25) 20.27 (20.44 to 20.11) 20.20
Teach to use prompts/cues 4 (19) 231 (1,603) 20.42 (20.86 to 0.03) 20.32 (20.47 to 20.17) 20.10
Relapse prevention/coping planning 11 (12) 543 (1,291) 20.33 (20.56 to 20.10) 20.32 (20.52 to 20.12) 20.01
Provide feedback on performance 7 (16) 336 (1,498) 20.31 (20.61 to 20.01) 20.33 (20.51 to 20.16) 0.02
Provide information on consequences
of behavior in general 10 (13) 417 (1,417) 20.24 (20.50 to 0.02) 20.36 (20.55 to 20.16) 0.12
Provide instruction on how to
perform the behavior 15 (8) 1,057 (777) 20.29 (20.47 to 20.10) 20.42 (20.64 to 20.20) 0.13
Action planning 6 (17) 339 (1,495) 20.23 (20.53 to 0.07) 20.37 (20.53 to 20.22) 0.14
Set graded tasks 10 (13) 1,252 (582) 20.26 (20.46 to 20.06) 20.42 (20.64 to 20.20) 0.16
Motivational interviewing 3 (20) 156 (1,678) 20.19 (20.58 to 0.19) 20.35 (20.51 to 20.19) 0.16
Prompt self-monitoring of behavior 16 (7) 656 (1,178) 20.18 (20.38 to 0.02) 20.47 (20.68 to 20.25) 0.29
Use $10 behavior change techniques 13 (10) 864 (970) 20.48 (20.67 to 20.30) 20.22 (20.42 to 20.03) 20.26
Mode of delivery
Combination of individual face-to-face
and group sessions 3 (20) 78 (1,756) 20.46 (21.00 to 0.08) 20.32 (20.48 to 20.16) 20.14
Individual face-to-face sessions only 12 (11) 1,428 (406) 20.33 (20.52 to 20.14) 20.32 (20.57 to 20.06) 20.01
Group sessions only 7 (16) 270 (1,564) 20.27 (20.64 to 0.09) 20.36 (20.50 to 20.22) 0.09
Theory or model of behavior change 18 (5) 1,638 (196) 20.37 (20.49 to 20.25) 20.21 (20.72 to 0.29) 20.16
Duration of intervention ($6 months) 12 (11) 1,378 (456) 20.40 (20.53 to 20.26) 20.23 (20.52 to 0.07) 20.17
Pedometer 8 (15) 377 (1,457) 20.21 (20.47 to 0.05) 20.38 (20.58 to 20.17) 0.25
Intensity of intervention ($14 contacts) 11 (12) 1,052 (782) 20.23 (20.40 to 20.07) 20.46 (20.66 to 20.26) 0.23
Supervised PA/exercise component 10 (13) 884 (950) 20.28 (20.48 to 20.07) 20.39 (20.58 to 20.19) 0.11
Moderator analyses include behavior change techniques and intervention features that were present or absent in each intervention arm compared with the usual care
arm across all 17 RCTs.
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previous successful attempts at PA);
barrier identification/problem solving
(e.g., identifying potential barriers to PA
and ways to overcome them); and pro-
viding information on the conse-
quences of PA specific to the individual
(e.g., information about the benefits and
costs of PA to individuals). This list of
behavior change techniques is not defini-
tive and is limited in terms of statistical
power by the available body of evidence.
More research is needed to determine ef-
fectiveness of single or aggregated behav-
ior change techniques in randomized trials
and to investigate how clusters of these
techniques could be individually tailored
for people with diabetes. To enhance re-
producibility, attention should also be
given to highlighting the utilization of spe-
cific behavior change techniques, with ref-
erence to a reliable taxonomy (19), when
describing intervention content. Because
HbA1c is influenced by the type, intensity,
and frequency of PA and exercise, it is pos-
sible that some of the behavior change
techniques were successful in changing
behavior, but that the level of PA and ex-
ercise achieved was insufficient to im-
prove glycemic control. The limited
description of intervention content in
studiesmay also limit the ability to identify
the success of a single behavior change
technique. As such, caution should be
given to dismissing some of the behavior
change techniques that, in the current re-
view, either were not identified or were
not associated with clinically significant
improvements in HbA1c. Exploratory
moderator analyses suggested that the
following intervention features were
associated with clinically significant im-
provements in HbA1c: underpinning
interventions with behavior change
theories/models (although no one model
appeared to hold benefit over others); uti-
lizing $10 behavior change techniques;
and intervention duration of $6 months.
Further research also is required to
determine what professional training en-
ables care providers to effectively deliver
behavioral interventions. Five studies re-
ported that individuals delivering the
interventions had been trained for this
purpose, but only two studies provided
information on mode, content, and utili-
zation of strategies for monitoring and
improving delivery of training. Profes-
sional training is a crucial component of
behavioral interventions because it im-
proves treatment fidelity and enhances
reproducibility in routine practice. Both
the mode of delivery and pathway of care
provider training have a significant
impact on the cost of delivering the
intervention and, as a result, the likeli-
hood of implementation in routine care.
Future studies, in addition to describing
behavior change theories, behavior
change techniques and how these were
operationalized also should report on
how care providers were trained and
aspects of treatment fidelity. This in-
creased clarity will assist in addressing
the current evidence-practice gap andwill
serve to increase the efficacy of PA as a
management option in routine diabetes
care.
Combined, these data reveal that be-
havioral interventions targeting increased
PA and exercise in clinical care or commu-
nity settings have significant clinical utility.
Although these observations are encourag-
ing, there remains a pressing need for
further research to understand how these
should be optimized and implemented into
routine clinical care.
AcknowledgmentsdThis study was funded
by the European Union Seventh Framework
Programme (FP7/2007-2013) under grant
agreement Health-F2-2009-241762 for the
project FLIP. L.A. is supported by a PhD
scholarship from the Newcastle Centre for
Brain Ageing and Vitality. M.I.T. is supported
by a Senior Fellowship from the National In-
stitute of Health Research. F.F.S. is funded by
Fuse, the Centre for Translational Research in
Public Health, a UK Clinical Research Col-
laboration Public Health Research Centre of
Excellence.
No conflicts of interest relevant to this ar-
ticle were reported.
L.A., D.F., F.F.S., and M.I.T. conceived the
review protocol. F.F.S. and M.I.T. supervised
the review. L.A., D.F., A.v.W., and F.F.S. de-
veloped the search strategy. L.A. performed
the electronic searches. L.A. and D.F. con-
ducted the screening of titles and abstracts and
evaluated the eligibility of full text articles. L.A.
and M.I.T. assessed included studies for
methodological quality and overall risk of bias
(within and across studies for each outcome).
L.A. and D.F. assessed included studies for
treatment fidelity. L.A. conducted the meta-
analyses and moderator analyses. All authors
provided input to the development of the
methods, data extraction, data analyses, and
drafting of the manuscript. M.I.T. is the
guarantor of this work and, as such, had full
access to all data in the study and takes re-
sponsibility for the integrity of the data and the
accuracy of the data analysis.
Elements of this systematic review were pre-
sented as a poster at the Diabetes UK Annual
Professional Conference, Glasgow, U.K., 7–9
March 2012.
The authors acknowledge the assistance of
Linda Errington, Assistant Librarian, Stephan
Dombrowski, Research Associate, and Andy
Bryant, ResearchAssistant (Statistician), from the
Faculty of Medical Sciences, Newcastle Univer-
sity, U.K., for guidance with electronic searching
and meta-analyses. The authors also thank the
corresponding authors of included studies who
responded to requests for additional data.
References
1. Wild S, Roglic G, Green A, Sicree R, King
H. Global prevalence of diabetes: esti-
mates for the year 2000 and projections
for 2030. Diabetes Care 2004;27:1047–
1053
2. Lazar MA. How obesity causes diabetes:
not a tall tale. Science 2005;307:373–375
3. Hill JO, Wyatt HR, Reed GW, Peters JC.
Obesity and the environment: where do
we go from here? Science 2003;299:853–
855
4. Taylor R. Pathogenesis of type 2 diabetes:
tracing the reverse route from cure to
cause. Diabetologia 2008;51:1781–1789
5. Morrato EH, Hill JO, Wyatt HR,
Ghushchyan V, Sullivan PW. Physical
activity in U.S. adults with diabetes and at
risk for developing diabetes, 2003. Di-
abetes Care 2007;30:203–209
6. Boulé NG, Haddad E, Kenny GP, Wells
GA, Sigal RJ. Effects of exercise on glyce-
mic control and body mass in type 2
diabetes mellitus: a meta-analysis of con-
trolled clinical trials. JAMA 2001;286:
1218–1227
7. Sigal RJ, Kenny GP, Wasserman DH,
Castaneda-Sceppa C. Physical activity/
exercise and type 2 diabetes. Diabetes
Care 2004;27:2518–2539
8. Zanuso S, Jimenez A, Pugliese G,
Corigliano G, Balducci S. Exercise for the
management of type 2 diabetes: a review
of the evidence. Acta Diabetol 2010;47:
15–22
9. Thomas DE, Elliott EJ, Naughton GA.
Exercise for type 2 diabetes mellitus.
Cochrane Database Syst Rev 2006;3:
CD002968
10. Snowling NJ, Hopkins WG. Effects of
different modes of exercise training on
glucose control and risk factors for com-
plications in type 2 diabetic patients:
a meta-analysis. Diabetes Care 2006;29:
2518–2527
11. Umpierre D, Ribeiro PAB, Kramer CK,
et al. Physical activity advice only or
structured exercise training and associa-
tion with HbA1c levels in type 2 diabetes:
a systematic review and meta-analysis.
JAMA 2011;305:1790–1799
12. Craig P, Dieppe P, Macintyre S, Michie S,
Nazareth I, Petticrew M. Developing and
evaluating complex interventions: the
new Medical Research Council Guidance.
BMJ 2008;337:a1655
care.diabetesjournals.org DIABETES CARE, VOLUME 35, DECEMBER 2012 2687
Avery and Associates
13. Michie S, Prestwich A. Are interventions
theory-based? Development of a theory
coding scheme. Health Psychol 2010;29:
1–8
14. Dombrowski SU, Sniehotta FF, Avenell S.
Towards a cumulative science of behav-
iour change: do current conduct and re-
porting of behavioural interventions fall
short of good practice? Psychol Health
2007;22:869–874
15. Avery L, Flynn D, van Wersch A, Trenell
MI, Sniehotta FF. A systematic review of
behaviour change interventions targeting
physical activity, exercise and HbA1c in




cessed 5 Dec 2011
16. Moher D, Liberati A, Tetzlaff J, Altman
DG; PRISMA Group. Preferred reporting
items for systematic reviews and meta-
analyses: the PRISMA statement. PLoS
Med 2009;6:e1000097
17. Higgins JPT, Green S (Eds.). Cochrane
handbook for systematic reviews of in-
terventions version 5.0.2, The Cochrane
Collaboration, 2009. Available fromwww.
cochrane-handbook.org. Accessed3March
2011
18. Bellg AJ, Borrelli B, Resnick B, et al.
Treatment FidelityWorkgroup of the NIH
Behavior Change Consortium. Enhancing
treatment fidelity in health behavior
change studies: best practices and rec-
ommendations from the NIH Behavior
Change Consortium. Health Psychol 2004;
23:443–451
19. Michie S, Ashford S, Sniehotta FF,
Dombrowski SU, Bishop A, French DP. A
refined taxonomy of behaviour change
techniques to help people change their
physical activity and healthy eating
behaviours: the CALO-RE taxonomy.
Psychol Health 2011;26:1479–1498
20. Higgins JPT, Thompson SG, Deeks JJ,
Altman DG. Measuring inconsistency in
meta-analyses. BMJ 2003;327:557–560
21. Balducci S, Zanuso S, Nicolucci A, et al.
Italian Diabetes Exercise Study (IDES)
Investigators. Effect of an intensive exer-
cise intervention strategy on modifiable
cardiovascular risk factors in subjects with
type 2 diabetes mellitus: a randomized
controlled trial: the Italian Diabetes and
Exercise Study (IDES). Arch Intern Med
2010;170:1794–1803
22. Balducci S, Zanuso S, Nicolucci A, et al.
Anti-inflammatory effect of exercise train-
ing in subjects with type 2 diabetes and the
metabolic syndrome is dependent on exer-
cise modalities and independent of weight
loss. Nutr Metab Cardiovasc Dis 2010;20:
608–617
23. Cheung NW, Cinnadaio N, Russo M,
Marek S. A pilot randomised controlled
trial of resistance exercise bands in the
management of sedentary subjects with
type 2 diabetes. Diabetes Res Clin Pract
2009;83:e68–e71
24. DeGreefK,Deforche B, Tudor-LockeC,De
Bourdeaudhuij I. A cognitive-behavioural
pedometer-based group intervention on
physical activity and sedentary behaviour
in individuals with type 2 diabetes. Health
Educ Res 2010;25:724–736
25. De Greef K, Deforche B, Tudor-Locke C,
De Bourdeaudhuij I. Increasing physical
activity in Belgian type 2 diabetes patients:
a three-arm randomized controlled trial.
Int J Behav Med 2011;18:188–198
26. De Greef KP, Deforche BI, Ruige JB, et al.
The effects of a pedometer-based behav-
ioral modification programwith telephone
support on physical activity and sedentary
behavior in type 2 diabetes patients. Pa-
tient Educ Couns 2011;84:275–279
27. Di Loreto C, Fanelli C, Lucidi P, et al.
Validation of a counseling strategy to
promote the adoption and the mainte-
nance of physical activity by type 2 di-
abetic subjects. Diabetes Care 2003;26:
404–408
28. Gram B, Christensen R, Christiansen C,
Gram J. Effects of nordic walking and
exercise in type 2 diabetes mellitus: a ran-
domized controlled trial. Clin J Sport Med
2010;20:355–361
29. Kim CJ, Kang DH. Utility of a Web-based
intervention for individuals with type 2
diabetes: the impact on physical activity
levels and glycemic control. Comput In-
form Nurs 2006;24:337–345
30. Kirk A, Mutrie N, MacIntyre P, Fisher M.
Effects of a 12-month physical activity
counselling intervention on glycaemic
control and on the status of cardiovascular
risk factors in people with Type 2 di-
abetes. Diabetologia 2004;47:821–832
31. Kirk A, Barnett J, Leese G, Mutrie N.
A randomized trial investigating the 12-
month changes in physical activity and
health outcomes following a physical ac-
tivity consultation delivered by a person
or in written form in Type 2 diabetes:
Time2Act. Diabet Med 2009;26:293–301
32. Ligtenberg PC, Hoekstra JBL, Bol E,
Zonderland ML, Erkelens DW. Effects of
physical training on metabolic control in
elderly type 2 diabetes mellitus patients.
Clin Sci (Lond) 1997;93:127–135
33. Plotnikoff RC, Eves N, Jung M, Sigal RJ,
Padwal R, Karunamuni N. Multicompo-
nent, home-based resistance training for
obese adults with type 2 diabetes: a ran-
domized controlled trial. Int J Obes
(Lond) 2010;34:1733–1741
34. Plotnikoff RC, Pickering MA, Glenn N,
et al. The effects of a supplemental,
theory-based physical activity counseling
intervention for adults with type 2 di-
abetes. J Phys Act Health 2011;8:944–954
35. Samaras K, Ashwell S, Mackintosh AM,
Fleury AC, Campbell LV, Chisholm DJ.
Will older sedentary people with non-
insulin-dependent diabetes mellitus start
exercising? A health promotion model.
Diabetes Res Clin Pract 1997;37:121–128
36. Tudor-Locke C, Bell RC, Myers AM, et al.
Controlled outcome evaluation of the
First Step Program: a daily physical ac-
tivity intervention for individuals with
type II diabetes. Int J Obes Relat Metab
Disord 2004;28:113–119
37. Wisse W, Rookhuizen MB, de Kruif MD,
et al. Prescription of physical activity is not
sufficient to change sedentary behavior
and improve glycemic control in type 2
diabetes patients. Diabetes Res Clin Pract
2010;88:e10–e13
38. Di Loreto C, Fanelli C, Lucidi P, et al.
Make your diabetic patients walk: long-
term impact of different amounts of physical
activity on type 2 diabetes. Diabetes Care
2005;28:1295–1302
39. Kirk A, Mutrie N, MacIntyre P, Fisher M.
Increasing physical activity in people with
type 2 diabetes. Diabetes Care 2003;26:
1186–1192
40. Kim CJ, Hwang AR, Yoo JS. The impact
of a stage-matched intervention to pro-
mote exercise behavior in participants
with type 2 diabetes. Int J Nurs Stud 2004;
41:833–841
41. Yoo JS, Hwang AR, Lee HC, Kim CJ.
Development and validation of a com-
puterized exercise intervention program
for patients with type 2 diabetes mellitus
in Korea. Yonsei Med J 2003;44:892–
904
42. Tudor-Locke CE, Myers AM, Rodger NW.
Development of a theory-based daily ac-
tivity intervention for individuals with
type 2 diabetes. Diabetes Educ 2001;27:
85–93
43. Tudor-Locke CE, Myers AM, Bell RC,
Harris SB, Wilson Rodger N. Preliminary
outcome evaluation of the First Step
Program: a daily physical activity in-
tervention for individuals with type 2
diabetes. Patient Educ Couns 2002;47:
23–28
44. Tudor-LockeC. Promoting lifestyle physical
activity: Experiences with the first step pro-
gram. Am J Lifestyle Med 2009;3(Suppl):
508–548
45. Calfas KJ, Long BJ, Sallis JF, Wooten WJ,
Pratt M, Patrick K. A controlled trial of
physician counseling to promote the adop-
tion of physical activity. Prev Med 1996;
25:225–233
46. van Sluijs EMF, van Poppel MNM, Twisk
JWR, Chin A Paw MJ, Calfas KJ, van
Mechelen W. Effect of a tailored physical
activity intervention delivered in general
practice settings: results of a randomized
controlled trial. Am J Public Health 2005;
95:1825–1831
47. Balducci S, Zanuso S, Massarini M, et al.
Italian Diabetes Exercise Study (IDES)
Group. The Italian Diabetes and Exercise
Study (IDES): design and methods for a
prospective Italian multicentre trial of in-
tensive lifestyle intervention in people
2688 DIABETES CARE, VOLUME 35, DECEMBER 2012 care.diabetesjournals.org
Changing physical activity behavior in diabetes
with type 2 diabetes and the metabolic
syndrome. Nutr Metab Cardiovasc Dis
2008;18:585–595
48. UK Prospective Diabetes Study (UKPDS)
Group. Intensive blood-glucose control
with sulphonylureas or insulin compared
with conventional treatment and risk of
complications in patients with type 2 di-
abetes (UKPDS 33). Lancet 1998;352:
837–853
49. UK Prospective Diabetes Study (UKPDS)
Group. Effect of intensive blood-glucose
control with metformin on complica-
tions in overweight patients with type 2
diabetes (UKPDS 34). Lancet 1998;352:
854–865
50. Miller WC, Koceja DM, Hamilton EJ. A
meta-analysis of the past 25 years of weight
loss research using diet, exercise or diet plus
exercise intervention. Int J Obes Relat
Metab Disord 1997;21:941–947
care.diabetesjournals.org DIABETES CARE, VOLUME 35, DECEMBER 2012 2689
Avery and Associates
